Search icon

ECLIPSE PHARMACEUTICALS, INC. - Florida Company Profile

Company Details

Entity Name: ECLIPSE PHARMACEUTICALS, INC.
Jurisdiction: FLORIDA
Filing Type: Domestic Profit

ECLIPSE PHARMACEUTICALS, INC. is structured as a Domestic Profit Corporation, which, in Florida signifies a Profit Corporation (also known as a C-Corporation). This business structure is recognized as a separate legal entity from its owners. This offers shareholders the benefit of limited liability protection, safeguarding their personal assets from the corporation's debts and obligations, and facilitates raising capital through the issuance of stock. In Florida, Domestic Profit Corporations are governed by Title XXXVI, Chapter 607, Florida Statutes – Florida Business Corporation Act.

Status: Inactive

The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders.

Date Filed: 17 Nov 2011 (13 years ago)
Date of dissolution: 08 Jan 2015 (10 years ago)
Last Event: VOLUNTARY DISSOLUTION
Event Date Filed: 08 Jan 2015 (10 years ago)
Document Number: P11000099409
FEI/EIN Number 208982718

Federal Employer Identification (FEI) Number assigned by the IRS.

Address: 3505 Lake Lynda Drive, ORLANDO, FL, 32817, US
Mail Address: 3505 Lake Lynda Drive, ORLANDO, FL, 32817, US
ZIP code: 32817
County: Orange
Place of Formation: FLORIDA

form 5500

Plan Name Plan Year EIN/PN Received Sponsor Total number of participants
ECLIPSE PHARMACEUTICALS, INC 401K PLAN 2014 208982718 2015-11-17 ECLIPSE PHARMACEUTICALS, INC 5
Three-digit plan number (PN) 001
Effective date of plan 2012-03-01
Business code 541600
Sponsor’s telephone number 9086352326
Plan sponsor’s address 5790, SUITE 200, ORLANDO, FL, 32822

Signature of

Role Plan administrator
Date 2015-11-17
Name of individual signing TODD MACLAUGHLAN
Valid signature Filed with authorized/valid electronic signature
ECLIPSE PHARMACEUTICALS, INC 401K PLAN 2014 208982718 2016-01-22 ECLIPSE PHARMACEUTICALS, INC 5
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2012-03-01
Business code 541600
Sponsor’s telephone number 9086352326
Plan sponsor’s address 5790, SUITE 200, ORLANDO, FL, 32822

Signature of

Role Plan administrator
Date 2016-01-22
Name of individual signing TODD MACLAUGHLAN
Valid signature Filed with authorized/valid electronic signature
ECLIPSE PHARMACEUTICALS, INC 401K PLAN 2013 208982718 2014-09-01 ECLIPSE PHARMACEUTICALS, INC 4
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2012-03-01
Business code 541600
Sponsor’s telephone number 9086352326
Plan sponsor’s address 3505 LAKE LYNDA DR, SUITE 200, ORLANDO, FL, 32817

Signature of

Role Plan administrator
Date 2014-09-01
Name of individual signing TODD MACLAUGHLAN
Valid signature Filed with authorized/valid electronic signature
ECLIPSE PHARMACEUTICALS, INC 401K PLAN 2012 208982718 2013-07-03 ECLIPSE PHARMACEUTICALS, INC 3
File View Page
Three-digit plan number (PN) 001
Effective date of plan 2012-03-01
Business code 541600
Sponsor’s telephone number 9086729790
Plan sponsor’s address 3010 SUMMER SWAN DR, ORLANDO, FL, 32825

Signature of

Role Plan administrator
Date 2013-07-03
Name of individual signing TODD MACLAUGHLAN
Valid signature Filed with authorized/valid electronic signature

Key Officers & Management

Name Role Address
MACLAUGHLAN TODD Chief Executive Officer 3505 Lake Lynda Drive, ORLANDO, FL, 32817
MACLAUGHLAN TODD Agent 3505 Lake Lynda Drive, ORLANDO, FL, 32817

Events

Event Type Filed Date Value Description
VOLUNTARY DISSOLUTION 2015-01-08 - -
CHANGE OF PRINCIPAL ADDRESS 2014-03-21 3505 Lake Lynda Drive, Suite 200, ORLANDO, FL 32817 -
CHANGE OF MAILING ADDRESS 2014-03-21 3505 Lake Lynda Drive, Suite 200, ORLANDO, FL 32817 -
REGISTERED AGENT ADDRESS CHANGED 2014-03-21 3505 Lake Lynda Drive, Suite 200, ORLANDO, FL 32817 -

Documents

Name Date
VOLUNTARY DISSOLUTION 2015-01-08
ANNUAL REPORT 2014-03-21
ANNUAL REPORT 2013-03-23
ANNUAL REPORT 2012-01-14
Domestic Profit 2011-11-17

Date of last update: 03 Apr 2025

Sources: Florida Department of State